Pre-Test: “Smart” Therapy in Heart Failure: From Remote Monitoring to Assisted Circulation

“Smart” Therapy in Heart Failure: From Remote Monitoring to Assisted Circulation

Question Title

* 1. The earliest detectable physiological change(s) on the road to heart failure decompensation / hospitalization are:

A. Worsening symptoms and increases in body weight

B. Changes in autonomic balance and biomarkers indicative of congestion

C. Increases in intra-cardiac and pulmonary artery pressures

D. None of the above

Question Title

* 2. Remote telemonitoring of signs, symptoms, and daily weights improves which of the following:

A. Quality of life

B. Risk of heart failure hospitalization

C. Combined risk of morbidity (hospitalization) and mortality

D. None of the above

Question Title

* 3. Which of the following statements regarding remote monitoring of heart failure patients is true?

A. Routine telemonitoring of weight and vital signs in heart failure patients reduces heart failure hospitalizations

B. Improvement in cardiac function occurs with ASCT but not with chemotherapy alone

C. Longitudinal monitoring of intrathoracic impedance reduces heart failure hospitalizations compared with routine heart failure management

D. Wireless hemodynamic monitoring reduces heart failure hospitalizations equally in low EF heart failure patients and preserved EF heart failure patients

Question Title

* 4. Which of the following reflects the recommended approach to management of high PA pressures in the CHAMPION Trial?

A. Optimize guideline-directed medical therapy

B. Adjust diuretics, then vasodilators

C. Adjust vasodilators, then diuretics

D. Advise dietary modification initially, then adjust diuretics

Question Title

* 5. Given the known outcomes with mitral valve repair for functional MR in patients with advanced chronic systolic heart failure, percutaneous mitral valve repair and replacement is likely to improve survival, quality of life and functional capacity in these patients?

A. True

B. False

Question Title

* 6. In patients with LVEF ≤ 35% and coronary anatomy amenable to revascularization, submaximal functional capacity and physical activity level may help to identify patients most likely to benefit from CABG, with the greatest benefit in those with the most impaired functional capacity/activity level?

A. True

B. False

Question Title

* 7. One complication selectively increasingly encountered with continuous flow rather than pulsatile LVAD systems is:

A. Aortic stenosis

B. Gastrointestinal Bleeding

C. Tricuspid Regurgitation

D. Stroke

Question Title

* 8. The LVAD system least likely to be associated with the complication of pump thrombosis is:

A. Heartmate II

B. Heartmate 3

C. Heartware HVAD

D. Berlin Heart

Question Title

* 9. When should a patient proceed towards VAD implant? i.e. which symptoms and signs of heart failure are considered irreversible and that the patient has increasing need for advanced therapies?

A. progressively worsening renal function

B. repeated hospitalizations for heart failure (more than 2 in the preceding year)

C. inability to optimize neurohormonal therapy due to hypotension

D. all of the above

Question Title

* 10. Please provide your first and last name.
Pre-test questions will not be scored, your name is required solely to confirm completion.

First Name & Last Name

Question Title

* 1. The earliest detectable physiological change(s) on the road to heart failure decompensation / hospitalization are:

Question Title

* 2. Remote telemonitoring of signs, symptoms, and daily weights improves which of the following:

Question Title

* 3. Which of the following statements regarding remote monitoring of heart failure patients is true?

Question Title

* 4. Which of the following reflects the recommended approach to management of high PA pressures in the CHAMPION Trial?

Question Title

* 5. Given the known outcomes with mitral valve repair for functional MR in patients with advanced chronic systolic heart failure, percutaneous mitral valve repair and replacement is likely to improve survival, quality of life and functional capacity in these patients?

Question Title

Question Title

* 7. One complication selectively increasingly encountered with continuous flow rather than pulsatile LVAD systems is:

Question Title

* 8. The LVAD system least likely to be associated with the complication of pump thrombosis is:

Question Title

* 9. When should a patient proceed towards VAD implant? i.e. which symptoms and signs of heart failure are considered irreversible and that the patient has increasing need for advanced therapies?

Question Title

* 10. Please provide your first and last name.Pre-test questions will not be scored, your name is required solely to confirm completion.

* 10. Please provide your first and last name.
Pre-test questions will not be scored, your name is required solely to confirm completion.